Pharma Journalist -

Lonza has entered into a new licensing agreement with biotechnology company InduPro to support the development of next-generation antibody-drug conjugate (ADC) therapies for cancer. The…
Read More...

Haisco Pharmaceutical Group has signed an exclusive licensing agreement with U.S.-based biotechnology company Nuvectis, granting the company rights to develop and commercialize two of…
Read More...

Combotope Therapeutics has entered into a strategic research collaboration with Boehringer Ingelheim to develop a new generation of tumor-selective antibody therapies for cancer. The…
Read More...

Abbisko Therapeutics has entered into a new strategic research collaboration and license agreement with Eli Lilly and Company to discover and develop innovative medicines across…
Read More...

Boehringer Ingelheim has announced the launch of three Phase III clinical trials aimed at advancing precision oncology for patients with some of the most aggressive forms of cancer. The…
Read More...

Voro Therapeutics and Alloy Therapeutics have entered into a strategic research collaboration aimed at developing a new generation of cancer immunotherapies designed to improve the…
Read More...

uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with refractory mesial temporal lobe epilepsy…
Read More...

Boltz PBC, an applied artificial intelligence research company focused on biomolecular modeling, has announced a new collaboration with Takeda aimed at bringing advanced AI-driven tools…
Read More...

SK pharmteco has entered into a new strategic collaboration with the Orphan Therapeutics Accelerator (OTXL), a non-profit biotechnology organization focused on advancing stalled rare…
Read More...

The success of GLP-1 medicines has changed the way healthcare professionals view obesity and metabolic diseases. Over the past few years, drugs such as semaglutide and tirzepatide have…
Read More...